Get startedLog in
    Picture of Inozyme Pharma logo

    INZY — Inozyme Pharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Inozyme Pharma To Present Recently Announced Preliminary Data From Ongoing Phase 1/2 Trial In Enpp1 Deficiency At Ects

    Picture of Inozyme Pharma logoInozyme Pharma
    14/04/2023 15:01
    April 14 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA TO PRESENT RECENTLY ANNOUNCED PRELIMINARY
DATA
FROM ONGOING PHASE 1/2 TRIAL IN ENPP1 DEFICIENCY AT THE EUROPEAN
CALCIFIED TISSUE SOCIETY CONGRESS (ECTS)
    * INOZYME PHARMA INC - COMPANY IS ON TRACK TO REPORT INTERIM
CLINICAL DATA IN Q3 OF 2023

Source text for Eikon:  ID:nGNXbvwQJ5 
Further company coverage:  INZY.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Inozyme Pharma

    See all news